Clinical Trial

Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-10
Trial Details
NCT Number NCT07567027
Lead Sponsor NYU Langone Health
Conditions Prostate Cancer (Diagnosis), Transperineal Cryoablation
Enrollment 20 participants
Start Date 2026-06-17
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-09